相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
Philipp Nuhn et al.
EUROPEAN UROLOGY (2019)
Application of the ASCO Value Framework and ESMO Magnitude of Clinical Benefit Scale to assess the value of abiraterone acetate (AA) and enzalutamide (E) in advanced prostate cancer: clinical value and cost considerations.
Sarah Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Stereotactic body radiation therapy for the treatment of oligoprogression on androgen receptor targeted therapy in castration-resistant prostate cancer
Thu-Cuc Nguyen et al.
OXFORD MEDICAL CASE REPORTS (2018)
Treatment strategies in low-volume metastatic castration-resistant prostate cancer
Xiao X. Wei et al.
CURRENT OPINION IN UROLOGY (2017)
Stereotactic ablative radiation therapy for the treatment of oligometastatic prostate cancer.
Phuoc T. Tran et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study
Luca Triggiani et al.
BRITISH JOURNAL OF CANCER (2017)
Imaging oligometastatic cancer before local treatment
James M. Franklin et al.
LANCET ONCOLOGY (2016)
The oligometastatic state-separating truth from wishful thinking
David A. Palma et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer
Kamran A. Ahmed et al.
FRONTIERS IN ONCOLOGY (2013)
分享论文
